PHARMA MAR, S.A. The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 17/12/2019 08:10 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Phama Mar submits New Drug Application for lurbinectedin under accelerated approval in small cell lung cancer in the USA. Register number: 284566 Related with 281246 of 19/08/2019 (08:27)
